TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2 (Q24630948)

2

0 references

James Davies

3

0 references

Chantal Colmont

4

0 references

Yves Laumonnier

5

0 references

Barbara Coles

6

0 references

Sanjoy Shah

7

0 references

Judith Hall

8

0 references

Nicholas Topley

9

0 references

Jörg Köhl

10

0 references

B Paul Morgan

11

0 references

Mario O Labéta

European Journal of Immunology

12

0 references

language of work or name

English

0 references

publication date

September 2011

0 references

published in

0 references

volume

41

0 references

issue

9

0 references

page(s)

2741-52

0 references

cites work

Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

C5L2 is a functional receptor for acylation-stimulating protein

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

The dark side of C5a in sepsis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Complement. First of two parts

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

C5L2, a nonsignaling C5A binding protein

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Expression and function of the C5a receptor in rat alveolar epithelial cells

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Complement: a key system for immune surveillance and homeostasis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Negative regulation of toll-like receptor-mediated immune responses

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Crosstalk pathways between Toll-like receptors and the complement system

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

The human complement fragment receptor, C5L2, is a recycling decoy receptor.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Therapeutic potential of HMGB1-targeting agents in sepsis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Functional roles for C5a receptors in sepsis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

C5L2--an anti-inflammatory molecule or a receptor for acylation stimulating protein (C3a-desArg)?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Structure and function of Toll receptors and their ligands

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Activation of Ca2+-dependent signaling by TLR2.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Role of HMGB1 in apoptosis-mediated sepsis lethality

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Evidence for a functional role of the second C5a receptor C5L2.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Historical review: a brief history and personal retrospective of seven-transmembrane receptors

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Role of C5a-C5aR interaction in sepsis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

Novel strategies for the treatment of sepsis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3638321

C5a negatively regulates toll-like receptor 4-induced immune responses

27 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041350

Microbial hijacking of complement-toll-like receptor crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041350

Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041350

Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041350

A Critical Role for C5L2 in the Pathogenesis of Experimental Allergic Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041350

Flow cytometric calcium flux assay: evaluation of cytoplasmic calcium kinetics in whole blood leukocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041350

Complement in inflammatory tissue damage and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041350

C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041350

Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses

21 January 2018

1 reference

12 December 2020

Expression and function of C5a receptor in mouse microvascular endothelial cells

1 reference

12 December 2020

Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis

1 reference

12 December 2020

Soluble CD14 acts as a negative regulator of human T cell activation and function

1 reference

12 December 2020

Toll-like receptors and innate immunity

1 reference

12 December 2020

Identifiers

DOI

10.1002/EJI.201041350

1 reference

1 reference

1 reference

PubMed publication ID

21630250

1 reference